the first agent to extend overall survival by targeting bone metastases in CRPC1,2- Bayer Healthcare

Home>Product>the first agent to extend overall survival by targeting bone metastases in CRPC1,2

the first agent to extend overall survival by targeting bone metastases in CRPC1,2

FOB Price:Get Latest Price >

Favorite

Bayer Healthcare

Business Type:Manufacturer

Country/Region:Germany

Ddu Verified

HOT Rank

8/10

Product Information

Description

You Might Also Like

Change a group

Inquiry Cart(0)

Products(0)
Suppliers(0)